Correlation Between Eupraxia Pharmaceuticals and Avax Techs
Can any of the company-specific risk be diversified away by investing in both Eupraxia Pharmaceuticals and Avax Techs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eupraxia Pharmaceuticals and Avax Techs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eupraxia Pharmaceuticals and Avax Techs, you can compare the effects of market volatilities on Eupraxia Pharmaceuticals and Avax Techs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eupraxia Pharmaceuticals with a short position of Avax Techs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eupraxia Pharmaceuticals and Avax Techs.
Diversification Opportunities for Eupraxia Pharmaceuticals and Avax Techs
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Eupraxia and Avax is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Eupraxia Pharmaceuticals and Avax Techs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avax Techs and Eupraxia Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eupraxia Pharmaceuticals are associated (or correlated) with Avax Techs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avax Techs has no effect on the direction of Eupraxia Pharmaceuticals i.e., Eupraxia Pharmaceuticals and Avax Techs go up and down completely randomly.
Pair Corralation between Eupraxia Pharmaceuticals and Avax Techs
Assuming the 90 days horizon Eupraxia Pharmaceuticals is expected to generate 0.75 times more return on investment than Avax Techs. However, Eupraxia Pharmaceuticals is 1.33 times less risky than Avax Techs. It trades about -0.03 of its potential returns per unit of risk. Avax Techs is currently generating about -0.06 per unit of risk. If you would invest 396.00 in Eupraxia Pharmaceuticals on September 1, 2024 and sell it today you would lose (117.00) from holding Eupraxia Pharmaceuticals or give up 29.55% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 54.28% |
| Values | Daily Returns |
Eupraxia Pharmaceuticals vs. Avax Techs
Performance |
| Timeline |
| Eupraxia Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Avax Techs |
Eupraxia Pharmaceuticals and Avax Techs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eupraxia Pharmaceuticals and Avax Techs
The main advantage of trading using opposite Eupraxia Pharmaceuticals and Avax Techs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eupraxia Pharmaceuticals position performs unexpectedly, Avax Techs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avax Techs will offset losses from the drop in Avax Techs' long position.| Eupraxia Pharmaceuticals vs. Akeso, Inc | Eupraxia Pharmaceuticals vs. Ascletis Pharma | Eupraxia Pharmaceuticals vs. Avax Techs | Eupraxia Pharmaceuticals vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |